P3.02c-028 Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)

MLA

Charu Aggarwal, et al. “P3.02c-028 Outcomes of Nivolumab in Elderly Patients (Pts) with Non-Small Cell Lung Cancer (NSCLC).” Journal of Thoracic Oncology, vol. 12, Jan. 2017, p. S1289. EBSCOhost, https://doi.org/10.1016/j.jtho.2016.11.1823.

APA

Charu Aggarwal, Tracey L. Evans, John A. Kosteva, Susan Stonehouse-Lee, Faith Mutale, Beth Eaby-Sandy, Anil Vachani, Joshua Bauml, Corey J. Langer, Elizabeth Gilbert, Shawn Kothari, Gloria Dilullo, Roger B. Cohen, Jeffrey C. Thompson, Christine Ciunci, Stephen J Bagley, Victoria Sherry, & Evan W. Alley. (2017). P3.02c-028 Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology, 12, S1289. https://doi.org/10.1016/j.jtho.2016.11.1823

Chicago

Charu Aggarwal, Tracey L. Evans, John A. Kosteva, Susan Stonehouse-Lee, Faith Mutale, Beth Eaby-Sandy, Anil Vachani, et al. 2017. “P3.02c-028 Outcomes of Nivolumab in Elderly Patients (Pts) with Non-Small Cell Lung Cancer (NSCLC).” Journal of Thoracic Oncology 12 (January): S1289. doi:10.1016/j.jtho.2016.11.1823.